105 A recent UK study has uncovered a potential method for diagnosing cancer earlier in patients presenting with non-specific abdominal symptoms such as pain and bloating. The research, published in the British Journal of Cancer, highlights how abnormalities in routine blood tests may serve as early indicators of cancer in some individuals, offering an opportunity for earlier intervention. The study analysed data from over 63,000 patients aged 30 and older who consulted GPs with new abdominal pain or bloating between 2007 and 2016. Researchers compared 10,575 patients diagnosed with cancer within a year of their initial symptoms with 52,875 matched controls who did not receive a cancer diagnosis. The findings revealed a marked difference in the use and results of blood tests between these two groups in the months leading up to diagnosis. Patients who were eventually diagnosed with cancer were significantly more likely to have undergone blood tests, with abnormal results becoming more frequent as diagnosis approached. The most common anomalies included raised inflammatory markers, high platelet counts, and low albumin levels. These abnormalities began to increase notably around seven months before cancer was detected, contrasting with much smaller changes in the control group. For men presenting with abdominal pain, raised platelet levels were particularly striking, showing a 33-fold increase compared to baseline levels. Similarly, women with abdominal pain or bloating exhibited marked rises in abnormal albumin levels, with increases of up to 41 times the baseline rate. These trends suggest that such blood test results could play a pivotal role in differentiating patients who require urgent cancer investigations. Despite these promising findings, the study’s authors stress that while abnormal blood tests may indicate cancer, they are not exclusive to it and often occur in benign conditions. Therefore, these results should be considered alongside other clinical factors, including patient symptoms and history, to enhance diagnostic accuracy. The research underscores the diagnostic challenges faced by GPs when patients present with vague symptoms. Many cancers detected in the study were diagnosed at an advanced stage, partly because abdominal symptoms are commonly associated with less serious conditions. Researchers believe integrating routine blood test results with advances in diagnostic tools could help identify high-risk patients earlier, potentially improving survival rates. This study represents an important step towards addressing delays in cancer diagnosis for patients with non-specific symptoms. By combining laboratory data with clinical observations, GPs may soon be better equipped to flag patients at risk and prioritise them for further testing, paving the way for earlier detection and improved outcomes.